- Home
- VANI vs GRABW Comparison
VANI vs GRABW Comparison
Compare VANI & GRABW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VANI
- GRABW
- Stock Information
- Founded
- VANI 1998
- GRABW 2012
- Country
- VANI United States
- GRABW Singapore
- Employees
- VANI N/A
- GRABW 11267
- Industry
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- GRABW Business Services
- Sector
- VANI Health Care
- GRABW Consumer Discretionary
- Exchange
- VANI Nasdaq
- GRABW Nasdaq
- Market Cap
- VANI 75.2M
- GRABW N/A
- IPO Year
- VANI 2014
- GRABW N/A
- Fundamental
- Price
- VANI $1.40
- GRABW $0.38
- Analyst Decision
- VANI Strong Buy
- GRABW
- Analyst Count
- VANI 1
- GRABW 0
- Target Price
- VANI $4.00
- GRABW N/A
- AVG Volume (30 Days)
- VANI 141.6K
- GRABW 54.7K
- Earning Date
- VANI 08-12-2025
- GRABW 02-21-2025
- Dividend Yield
- VANI N/A
- GRABW N/A
- EPS Growth
- VANI N/A
- GRABW N/A
- EPS
- VANI N/A
- GRABW N/A
- Revenue
- VANI N/A
- GRABW $2,686,000,000.00
- Revenue This Year
- VANI N/A
- GRABW N/A
- Revenue Next Year
- VANI N/A
- GRABW N/A
- P/E Ratio
- VANI N/A
- GRABW N/A
- Revenue Growth
- VANI N/A
- GRABW 21.65
- 52 Week Low
- VANI $0.91
- GRABW $0.15
- 52 Week High
- VANI $1.50
- GRABW $0.59
- Technical
- Relative Strength Index (RSI)
- VANI 74.26
- GRABW 48.92
- Support Level
- VANI $1.26
- GRABW $0.38
- Resistance Level
- VANI $1.30
- GRABW $0.40
- Average True Range (ATR)
- VANI 0.06
- GRABW 0.03
- MACD
- VANI 0.00
- GRABW 0.00
- Stochastic Oscillator
- VANI 69.70
- GRABW 66.67
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.
About GRABW Grab Holdings Limited Warrant
Founded in 2012, Grab provides ride-sharing services, food and grocery delivery, and financial services (payments, consumer loans, and enterprise offerings) in eight Southeast-Asian countries through its mobile platform. The company partners with merchants and riders, connecting them with consumers while charging commission to both sides. Grab has a leading market share in and derives 89% of its revenue from its core businesses, ride-sharing and food delivery. Singapore and Malaysia contributed 58% of revenue as of end-2021. Grab's main competitors in Southeast Asia are Foodpanda and Gojek, the ride-sharing arm of GoTo. Its financial services business is still in its nascent stage and provides minimal revenue currently. The company now also generates advertising revenue.